Optiver Holding
CHRS icon

Optiver Holding’s Coherus Oncology CHRS Stock Holding History

Optiver Holding’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Buy
10,081
+8,714
+637% +$14.2K ﹤0.01% 1651
2026
Q1 		$2.31K Sell
1,367
-3,777
-73% -$6.71K ﹤0.01% 1789
2025
Q4 		$7.3K Buy
5,144
+3,300
+179% +$4.81K ﹤0.01% 1221
2025
Q3 		$3.02K Buy
+1,844
New +$2.05K ﹤0.01% 2175

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Optiver Holding's CHRS Position: Q2 2026 in Review

Optiver Holding increased its Coherus Oncology (CHRS) stake by 637% in Q2 2026, buying an estimated $14.2K and bringing the position to 10,081 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

Optiver Holding first reported a position in CHRS in Q3 2025 and has held it in 4 quarters since. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Optiver Holding held 10,081 shares of Coherus Oncology worth $14.1K as of Q2 2026.
  • Optiver Holding bought 8,714 Coherus Oncology shares in Q2 2026, an estimated $14.2K.
  • Coherus Oncology made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1651 holding.
  • Optiver Holding first reported a position in Coherus Oncology in Q3 2025 and has held it in 4 quarters since.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.